CD46 on glial cells can function as a receptor for viral glycoprotein-mediated cell-cell fusion

Riccardo Cassiani-Ingoni1, Heather L Greenstone, Donatella Donati

  • 1Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

Glia
|May 28, 2005
PubMed

Insights

Oligodendrocytes express CD46, a complement regulator and viral entry receptor. This enables virus-infected cells to fuse with glial cells, potentially spreading infection within the nervous system.

Area of Science:

  • Neurovirology
  • Immunology
  • Cell Biology

Background:

  • Membrane cofactor protein (CD46) regulates complement and acts as an entry receptor for human herpesvirus 6 (HHV-6) and measles virus (MV).
  • Oligodendrocytes and astrocytes are known targets of HHV-6 and MV, but CD46 expression and infection mechanisms in oligodendrocytes remain unclear.

Purpose of the Study:

  • To investigate CD46 expression in oligodendrocytes and other glial cells.
  • To elucidate the cellular mechanisms of HHV-6 and MV infection in the central nervous system.

Main Methods:

  • Immunofluorescence to detect CD46 expression on oligodendrocytes, astrocytes, and microglial cells.
  • Quantitative fusion assays using HHV-6A-infected T lymphocytes and cells expressing recombinant MV glycoproteins.

Main Results:

  • Adult oligodendrocytes, astrocytes, and microglial cells express CD46 on their surface.
  • HHV-6A infection facilitated cell-cell fusion between infected T lymphocytes and glial cells (astrocytes and oligodendrocytes).
  • This fusion was mediated by viral glycoproteins interacting with CD46 on glial cells, and was also observed with MV glycoproteins.

Conclusions:

  • Oligodendrocytes express CD46, serving as a potential entry receptor for HHV-6 and MV.
  • Virus-mediated cell-cell fusion involving CD46 presents a mechanism for viral spread from peripheral cells to the central nervous system.
  • This finding has implications for understanding neuroinflammation and viral pathogenesis in the brain.